Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ida Skarping, Daniel Förnvik, Uffe Heide-Jørgensen, Lisa Rydén, Sophia Zackrisson & Signe Borgquist. (2020) Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study. Acta Oncologica 59:12, pages 1528-1537.
Read now
Read now
Shaukat Mahmood Mirza, James O’Brien & Jane Aitken. (2016) Reliability of MRI in Measuring the Response to Neoadjuvant Chemotherapy in Breast Cancer Patients and Its Therapeutic Implications. Breast Cancer Management 5:3, pages 107-118.
Read now
Read now
Joachim Böttcher, Diane M. Renz, Dirk-Michael Zahm, Alexander Pfeil, Eva M. Fallenberg, Florian Streitparth, Martin H. Maurer, Bernd Hamm & Florian J. Engelken. (2014) Response to neoadjuvant treatment of invasive ductal breast carcinomas including outcome evaluation: MRI analysis by an automatic CAD system in comparison to visual evaluation. Acta Oncologica 53:6, pages 759-768.
Read now
Read now
Articles from other publishers (67)
Mengfan Wang, Siyao Du, Si Gao, Ruimeng Zhao, Shasha Liu, Wenhong Jiang, Can Peng, Ruimei Chai & Lina Zhang. (2024) MRI-based tumor shrinkage patterns after early neoadjuvant therapy in breast cancer: correlation with molecular subtypes and pathological response after therapy. Breast Cancer Research 26:1.
Crossref
Crossref
Marjolijn M. Ladan, Titia G. Meijer, Nicole S. Verkaik, Cecile de Monye, Linetta B. Koppert, Esther Oomen-de Hoop, Carolien H. M. van Deurzen, Roland Kanaar, Julie Nonnekens, Dik C. van Gent & Agnes Jager. (2023) Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients. npj Breast Cancer 9:1.
Crossref
Crossref
Jessica H. Hayward, Olivia E. Linden, Alana A. Lewin, Susan P. Weinstein, Alexandra E. Bachorik, Tara M. Balija, Cherie M. Kuzmiak, Lisa V. Paulis, Lonie R. Salkowski, Matthew F. Sanford, John R. Scheel, Richard E. SharpeJr.Jr., William SmallJr.Jr., Gary A. Ulaner & Priscilla J. Slanetz. (2023) ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer: 2022 Update. Journal of the American College of Radiology 20:5, pages S125-S145.
Crossref
Crossref
Yafei Wang, Mengran Zhao, Yue Ma, Aidi Liu, Yueqiang Zhu, Lu Yin, Zhiran Liang, Zhiye Qu, Hong Lu, Ying Ma & Zhaoxiang Ye. (2023) Accuracy of Preoperative Contrast-enhanced Cone Beam Breast CT in Assessment of Residual Tumor after Neoadjuvant Chemotherapy: A Comparative Study with Breast MRI. Academic Radiology.
Crossref
Crossref
Zhao Bi, Peng-Fei Qiu, Tao Yang, Peng Chen, Xian-Rang Song, Tong Zhao, Zhao-Peng Zhang & Yong-Sheng Wang. (2022) The modified shrinkage classification modes could help to guide breast conserving surgery after neoadjuvant therapy in breast cancer. Frontiers in Oncology 12.
Crossref
Crossref
Mi-ri Kwon, Jinah Chu, Shin Ho Kook & Eun Young Kim. (2022) Factors associated with radiologic-pathologic discordance in magnetic resonance imaging after neoadjuvant chemotherapy for breast cancer. Clinical Imaging 89, pages 1-9.
Crossref
Crossref
Cecilia Mercado, Chloe Chhor & John R Scheel. (2022) MRI in the Setting of Neoadjuvant Treatment of Breast Cancer. Journal of Breast Imaging 4:3, pages 320-330.
Crossref
Crossref
Miloš Počekovac, Kristina Davidović, Mirjana Stojanović, Milena Stojanović, Slađana Mihajlović, Slađana Marković & Jovo Paskaš. (2022) Progesterone and oestrogen receptor status in breast carcinoma in surgically treated women relative to age. Glasnik javnog zdravlja 96:2, pages 178-185.
Crossref
Crossref
Sandy C. Lee, Hisham Tchelepi, Nasim Khadem, Bhushan Desai, Mary Yamashita & Linda Hovanessian-Larsen. (2022) Imaging of Benign and Malignant Breast Lesions Using Contrast-Enhanced Ultrasound. Ultrasound Quarterly 38:1, pages 2-12.
Crossref
Crossref
Uzma Waheed & John W. HallIVIV. 2022. Management of the Breast and Axilla in the Neoadjuvant Setting. Management of the Breast and Axilla in the Neoadjuvant Setting
85
121
.
Eneida Turiján-Espinoza, Víctor Manuel Ruíz-Rodríguez, Edith Elena Uresti-Rivera, Ernesto Martínez-Leija, José de Jesús Zermeño-Nava, Arturo Guel-Pañola, Silvia Romano-Moreno, Juan Manuel Vargas-Morales & Diana Patricia Portales-Pérez. (2021) Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients. Cancer Chemotherapy and Pharmacology 87:6, pages 843-853.
Crossref
Crossref
Ayane Yamaguchi, Maya Honda, Hiroshi Ishiguro, Masako Kataoka, Tatsuki R. Kataoka, Hanako Shimizu, Masae Torii, Yukiko Mori, Nobuko Kawaguchi-Sakita, Kentaro Ueno, Masahiro Kawashima, Masahiro Takada, Eiji Suzuki, Yuji Nakamoto, Kosuke Kawaguchi & Masakazu Toi. (2021) Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study. Scientific Reports 11:1.
Crossref
Crossref
Hyun Soo Ahn, Yeong Yi An, Ye Won Jeon, Young Jin Suh & Hyun-Joo Choi. (2021) Evaluation of Post-Neoadjuvant Chemotherapy Pathologic Complete Response and Residual Tumor Size of Breast Cancer: Analysis on Accuracy of MRI and Affecting Factors. Journal of the Korean Society of Radiology 82:3, pages 654.
Crossref
Crossref
Meliha Akin, Sebnem Orguc, Feray Aras & Ali Riza Kandiloglu. (2020) Molecular subtypes of invasive breast cancer: correlation between PET/computed tomography and MRI findings. Nuclear Medicine Communications 41:8, pages 810-816.
Crossref
Crossref
Shi-Chong Zhou, Jian Le, Jin Zhou, Yun-Xia Huang, Lang Qian & Cai Chang. (2020) The Role of Contrast-Enhanced Ultrasound in the Diagnosis and Pathologic Response Prediction in Breast Cancer: A Meta-analysis and Systematic Review. Clinical Breast Cancer 20:4, pages e490-e509.
Crossref
Crossref
Ameer Hamza, Sidrah Khawar, Ramen Sakhi, Ahmed Alrajjal, Shelby Miller, Warda Ibrar, Jacob Edens, Sajad Salehi & Daniel Ockner. (2018) Factors affecting the concordance of radiologic and pathologic tumor size in breast carcinoma. Ultrasound 27:1, pages 45-54.
Crossref
Crossref
Ameer Hamza, Ramen Sakhi, Ahmed Alrajjal, Warda Ibrar, Shelby Miller, Sajad Salehi, Jacob Edens & Daniel Ockner. (2018) Tumor Size in Breast Carcinoma: Gross Measurement Is Important!. International Journal of Surgical Pathology 26:6, pages 494-499.
Crossref
Crossref
John R. ScheelEunhee KimSavannah C. PartridgeConstance D. LehmanMark A. RosenWanda K. BernreuterEtta D. PisanoHelga S. MarquesElizabeth A. MorrisPaul T. WeatherallSandra M. PolinGillian M. NewsteadLaura J. EssermanMitchell D. SchnallNola M. Hylton. (2018) MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial. American Journal of Roentgenology 210:6, pages 1376-1385.
Crossref
Crossref
Huong T. Le-Petross & Bora Lim. (2018) Role of MR Imaging in Neoadjuvant Therapy Monitoring. Magnetic Resonance Imaging Clinics of North America 26:2, pages 207-220.
Crossref
Crossref
E. Fernández Cuadriello. (2018) Revisión del estado actual de la resonancia magnética en el cáncer de mama. Clínica e Investigación en Ginecología y Obstetricia 45:2, pages 69-77.
Crossref
Crossref
S. Di Cosimo, C. Campbell, H.A. AzimJr.Jr., G. Galli, G. Bregni, G. Curigliano, C. Criscitiello, M. Izquierdo, L. de la Pena, D. Fumagalli, L. Fein, J. Vinholes, W.M.J. Ng, M. Colleoni, A. Ferro, B.J. Naume, A. Patel, J. Huober, M.J. Piccart-Gebhart, J. Baselga & E. de Azambuja. (2018) The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO. European Journal of Cancer 89, pages 42-48.
Crossref
Crossref
Priscilla J. Slanetz, Linda Moy, Paul Baron, Roberta M. diFlorio, Edward D. Green, Samantha L. Heller, Anna I. Holbrook, Su-Ju Lee, Alana A. Lewin, Ana P. Lourenco, Bethany Niell, Ashley R. Stuckey, Sunita Trikha, Nina S. Vincoff, Susan P. Weinstein, Monica M. Yepes & Mary S. Newell. (2017) ACR Appropriateness Criteria ® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer. Journal of the American College of Radiology 14:11, pages S462-S475.
Crossref
Crossref
Qi Zhang, Congcong Yuan, Wei Dai, Lei Tang, Jun Shi, Zuoyong Li & Man Chen. (2017) Evaluating pathologic response of breast cancer to neoadjuvant chemotherapy with computer-extracted features from contrast-enhanced ultrasound videos. Physica Medica 39, pages 156-163.
Crossref
Crossref
Yan-Lin Gu, Si-Meng Pan, Jie Ren, Zhi-Xue Yang & Guo-Qin Jiang. (2017) Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis. Clinical Breast Cancer 17:4, pages 245-255.
Crossref
Crossref
C. Brisson, C. Diguisto, A. Vildé, G. Body, F. Arbion, J. Leveque & L. Ouldamer. (2017) Performances de l’imagerie par résonance magnétique au cours des chimiothérapies néoadjuvantes du cancer du sein pour prédire la réponse pathologique complète. Journal of Gynecology Obstetrics and Human Reproduction 46:2, pages 147-154.
Crossref
Crossref
H. T. Carisa Le-Petross, Bora Lim & Nola Hylton. 2017. Breast Oncology: Techniques, Indications, and Interpretation. Breast Oncology: Techniques, Indications, and Interpretation
103
120
.
Woo Jung Choi, Joo Hee Cha, Hak Hee Kim, Hee Jung Shin & Eun Young Chae. (2016) The Accuracy of Breast MR Imaging for Measuring the Size of a Breast Cancer: Analysis of the Histopathologic Factors. Clinical Breast Cancer 16:6, pages e145-e152.
Crossref
Crossref
Sneha Phadke, Alexandra Thomas, Limin Yang, Catherine Moore, Chang Xia & Mary C. Schroeder. (2016) Frequency and Clinical Significance of Extramammary Findings on Breast Magnetic Resonance Imaging. Clinical Breast Cancer 16:5, pages 424-429.
Crossref
Crossref
Atilla Soran, Rohit Bhargava, Ronald Johnson, Gretchen Ahrendt, Marguerite Bonaventura, Emilia Diego, Priscilla F. McAuliffe, Merida Serrano, Ebru Menekse, Efe Sezgin & Kandace P. McGuire. (2016) The impact of Oncotype DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer. Breast Disease 36:2-3, pages 65-71.
Crossref
Crossref
Juan Zhou, Gongjie Li, Fugeng Sheng, Penggang Qiao, Hongtao Zhang & Xudong Xing. (2015) Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications. Acta Radiologica 57:5, pages 529-537.
Crossref
Crossref
Alberto Bouzón, Benigno Acea, Rafaela Soler, Ángela Iglesias, Paz Santiago, Joaquín Mosquera, Lourdes Calvo, Teresa Seoane-Pillado & Alejandra García. (2016) Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients. Radiology and Oncology 50:1, pages 73-79.
Crossref
Crossref
Michael L. Marinovich, Petra Macaskill, Les Irwig, Francesco Sardanelli, Eleftherios Mamounas, Gunter von Minckwitz, Valentina Guarneri, Savannah C. Partridge, Frances C. Wright, Jae Hyuck Choi, Madhumita Bhattacharyya, Laura Martincich, Eren Yeh, Viviana Londero & Nehmat Houssami. (2015) Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis. BMC Cancer 15:1.
Crossref
Crossref
Marie Catherine Lee, Segundo Jaime Gonzalez, Huiyi Lin, Xiuhua Zhao, John V. Kiluk, Christine Laronga & Blaise Mooney. (2015) Prospective Trial of Breast MRI Versus 2D and 3D Ultrasound for Evaluation of Response to Neoadjuvant Chemotherapy. Annals of Surgical Oncology 22:9, pages 2888-2894.
Crossref
Crossref
Bo Bae Choi & Sung Hun Kim. (2015) Effective factors to raise diagnostic performance of breast MRI for diagnosing pathologic complete response in breast cancer patients after neoadjuvant chemotherapy. Acta Radiologica 56:7, pages 790-797.
Crossref
Crossref
Christobel Saunders & Donna Taylor. (2015)
Expanding the indications for
MRI
in the diagnosis and treatment of breast cancer: what is best practice?
. Journal of Medical Radiation Sciences 62:1, pages 47-53.
Crossref
Crossref
Yan-Ling Li, Xiao-Peng Zhang, Jie Li, Kun Cao, Yong Cui, Xiao-Ting Li & Ying-Shi Sun. (2015) MRI in diagnosis of pathological complete response in breast cancer patients after neoadjuvant chemotherapy. European Journal of Radiology 84:2, pages 242-249.
Crossref
Crossref
Kandace P. McGuire, E. Shelley Hwang, Alan Cantor, Mehra Golshan, Funda Meric-Bernstam, Janet K. Horton, Rita Nanda, Keith D. Amos, Andres Forero, Cliff A. Hudis, Ingrid Meszoely & Jennifer F. De Los Santos. (2014) Surgical Patterns of Care in Patients with Invasive Breast Cancer Treated with Neoadjuvant Systemic Therapy and Breast Magnetic Resonance Imaging: Results of a Secondary Analysis of TBCRC 017. Annals of Surgical Oncology 22:1, pages 75-81.
Crossref
Crossref
Sheng Chen, Yin Liu, Qian-Wen Ouyang, Liang Huang, Rong-Cheng Luo & Zhi-Ming Shao. (2014) Clinical and Pathological Response to Neoadjuvant Chemotherapy Based on Primary Tumor Reduction is Correlated to Survival in Hormone Receptor-Positive but not Hormone Receptor-Negative Locally Advanced Breast Cancer. Annals of Surgical Oncology 22:1, pages 32-39.
Crossref
Crossref
Enida Bufi, Paolo Belli, Marialuisa Di Matteo, Daniela Terribile, Gianluca Franceschini, Luigia Nardone, Gianluigi Petrone & Lorenzo Bonomo. (2014) Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment. European Journal of Radiology 83:9, pages 1631-1638.
Crossref
Crossref
Jeon‐Hor Chen, Shadfar Bahri, Rita S. Mehta, Philip M. Carpenter, Christine E. McLaren, Wen‐Pin Chen, Peter T. Fwu, David J. B. Hsiang, Karen T. Lane, John A. Butler & Min‐Ying Su. (2013) Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology. Journal of Surgical Oncology 109:2, pages 158-167.
Crossref
Crossref
D. Groheux, C. Rousseau, F. Kraeber-Bodéré, L. Quéro, S. Delanian & C. de Bazelaire. 2014. Imagerie Post-Thérapeutique en Oncologie. Imagerie Post-Thérapeutique en Oncologie
77
118
.
Rita A. Mukhtar, Christina Yau, Mark Rosen, Vickram J. Tandon, Nola Hylton & Laura J. Esserman. (2013) Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Annals of Surgical Oncology 20:12, pages 3823-3830.
Crossref
Crossref
Mindy Williams, Jennifer Eatrides, Jongphil Kim, Harpreet Talwar, Nicole Esposito, Margaret Szabunio, Roohi Ismail-Khan, John Kiluk, Marie Lee, Christine Laronga & Nazanin Khakpour. (2013) Comparison of breast magnetic resonance imaging clinical tumor size with pathologic tumor size in patients status post-neoadjuvant chemotherapy. The American Journal of Surgery 206:4, pages 567-573.
Crossref
Crossref
Eun Sook Ko, Boo-Kyung Han, Rock Bum Kim, Eun Young Ko, Jung Hee Shin, Soo Yeon Hahn, Seok Jin Nam, Jeong Eon Lee, Se Kyung Lee, Young-Hyuck Im & Yeon Hee Park. (2013) Analysis of Factors that Influence the Accuracy of Magnetic Resonance Imaging for Predicting Response after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. Annals of Surgical Oncology 20:8, pages 2562-2568.
Crossref
Crossref
M. B. I. Lobbes, R. Prevos, M. Smidt, V. C. G. Tjan-Heijnen, M. van Goethem, R. Schipper, R. G. Beets-Tan & J. E. Wildberger. (2013) The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review. Insights into Imaging 4:2, pages 163-175.
Crossref
Crossref
A. Romero, J.A. García-Sáenz, M. Fuentes-Ferrer, J.A. López Garcia-Asenjo, V. Furió, J.M. Román, A. Moreno, M. de la Hoya, E. Díaz-Rubio, M. Martín & T. Caldés. (2013) Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients. Annals of Oncology 24:3, pages 655-661.
Crossref
Crossref
Doo Kyoung Kang, Tae Hee Kim, Tae Sun Han, Ku Sang Kim & Hyunee Yim. (2013) Magnetic Resonance Imaging Enhancement Features Before and After Neoadjuvant Chemotherapy in Patients With Breast Cancer. Journal of Computer Assisted Tomography 37:3, pages 432-439.
Crossref
Crossref
Carlo Mariotti & Luis J. Sánchez. 2013. What’s New in Surgical Oncology. What’s New in Surgical Oncology
229
254
.
Masakazu Toi, John R. Benson, Eric P. Winer, John F. Forbes, Gunter von Minckwitz, Mehra Golshan, John F. R. Robertson, Hironobu Sasano, Bernard F. Cole, Louis W. C. Chow, Mark D. Pegram, Wonshik Han, Chiun-Sheng Huang, Tadashi Ikeda, Shotaro Kanao, Eun-Sook Lee, Shinzaburo Noguchi, Shinji Ohno, Ann H. Partridge, Roman Rouzier, Mitsuhiro Tozaki, Tomoharu Sugie, Akira Yamauchi & Takashi Inamoto. (2012) Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference. Breast Cancer Research and Treatment 136:3, pages 919-926.
Crossref
Crossref
E Bufi, P Belli, M Costantini, P Rinaldi, M Di Matteo, A Bonatesta, M C De Santis, L Nardone, D Terribile, A Mulé & L Bonomo. (2012) MRI evaluation of neoadjuvant low-dose fractionated radiotherapy with concurrent chemotherapy in patients with locally advanced breast cancer. The British Journal of Radiology 85:1019, pages e995-e1103.
Crossref
Crossref
M. B. I. Lobbes. (2012) Treatment response evaluation by MRI in breast cancer patients receiving neoadjuvant chemotherapy: there is more than just pathologic complete response prediction. Breast Cancer Research and Treatment 136:1, pages 313-314.
Crossref
Crossref
Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Shiro Tanaka & Kaori Togashi. (2012) MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy. European Journal of Radiology 81:9, pages 2148-2153.
Crossref
Crossref
Debora Fumagalli, Philippe L Bedard, Zeina Nahleh, Stefan Michiels, Christos Sotiriou, Sherene Loi, Joseph A Sparano, Matthew Ellis, Nola Hylton, Jo Anne Zujewski, Clifford Hudis, Laura Esserman & Martine Piccart. (2012) A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints. The Lancet Oncology 13:6, pages e240-e248.
Crossref
Crossref
Sarah Ines Ramirez, Max Scholle, Jennifer Buckmaster, Robert Hunter Paley & Gopal Chandru Kowdley. (2012) Breast Cancer Tumor Size Assessment with Mammography, Ultrasonography, and Magnetic Resonance Imaging at a Community Based Multidisciplinary Breast Center. The American Surgeon 78:4, pages 440-446.
Crossref
Crossref
Aida Kuzucan, Jeon-Hor Chen, Shadfar Bahri, Rita S. Mehta, Philip M. Carpenter, Peter T. Fwu, Hon J. Yu, David J.B. Hsiang, Karen T. Lane, John A. Butler, Stephen A. Feig & Min-Ying Su. (2012) Diagnostic Performance of Magnetic Resonance Imaging for Assessing Tumor Response in Patients With HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy is Associated With Molecular Biomarker Profile. Clinical Breast Cancer 12:2, pages 110-118.
Crossref
Crossref
Marc Lobbes, Renate Prevos & Marjolein Smidt. (2012) Response monitoring of breast cancer patientsreceiving neoadjuvant chemotherapy using breast MRI – a review of current knowledge. journal of Cancer Therapeutics and Research 1:1, pages 34.
Crossref
Crossref
Paolo Belli, Melania Costantini, Carmine Ierardi, Enida Bufi, Daniele Amato, Antonino Mule’, Luigia Nardone, Daniela Terribile & Lorenzo Bonomo. (2011) Diffusion-weighted Imaging in Evaluating the Response to Neoadjuvant Breast Cancer Treatment. The Breast Journal 17:6, pages 610-619.
Crossref
Crossref
Kandace P. McGuire, Jorge Toro-Burguete, Hang Dang, Jessica Young, Atilla Soran, Margarita Zuley, Rohit Bhargava, Marguerite Bonaventura, Ronald Johnson & Gretchen Ahrendt. (2011) MRI Staging After Neoadjuvant Chemotherapy for Breast Cancer: Does Tumor Biology Affect Accuracy?. Annals of Surgical Oncology 18:11, pages 3149-3154.
Crossref
Crossref
Valentina Guarneri, Annarita Pecchi, Federico Piacentini, Elena Barbieri, Maria Vittoria Dieci, Guido Ficarra, Giovanni Tazzioli, Antonio Frassoldati, Rachele Battista, Barbara Canossi, Claudia Mauri, Roberto D’Amico, PierFranco Conte & Pietro Torricelli. (2011) Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II–III Breast Cancer. Annals of Surgical Oncology 18:8, pages 2150-2157.
Crossref
Crossref
Rebekah McLaughlin & Nola Hylton. (2011) MRI in breast cancer therapy monitoring. NMR in Biomedicine, pages n/a-n/a.
Crossref
Crossref
J. Camps Herrero. (2011) Resonancia magnética de mama: estado actual y aplicación clínica. Radiología 53:1, pages 27-38.
Crossref
Crossref
J. Camps Herrero. (2011) Breast Magnetic Resonance Imaging: State of the art and clinical applications. Radiología (English Edition) 53:1, pages 27-38.
Crossref
Crossref
H. Carisa Le-Petross & Nola Hylton. (2010) Role of Breast MR Imaging in Neoadjuvant Chemotherapy. Magnetic Resonance Imaging Clinics of North America 18:2, pages 249-258.
Crossref
Crossref
Francesco Sardanelli, Carla Boetes, Bettina Borisch, Thomas Decker, Massimo Federico, Fiona J. Gilbert, Thomas Helbich, Sylvia H. Heywang-Köbrunner, Werner A. Kaiser, Michael J. Kerin, Robert E. Mansel, Lorenza Marotti, Laura Martincich, Louis Mauriac, Hanne Meijers-Heijboer, Roberto Orecchia, Pietro Panizza, Antonio Ponti, Arnie D. Purushotham, Peter Regitnig, Marco Rosselli Del Turco, Fabienne Thibault & Robin Wilson. (2010) Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group. European Journal of Cancer 46:8, pages 1296-1316.
Crossref
Crossref
Thomas Schlossbauer, Steven Sourbron, Anna Scholz, Marc Mosner, Steffen Kahlert, Holger Böhm, Maximilian Reiser & Karin Hellerhoff. (2010) Dynamic Breast MRI in the Course of Neoadjuvant Chemotherapy. Academic Radiology 17:4, pages 441-449.
Crossref
Crossref
Nabil Wasif, Jennifer Garreau, Alicia Terando, Daniel Kirsch, Debra F. Mund & Armando E. Giuliano. (2009) MRI versus Ultrasonography and Mammography for Preoperative Assessment of Breast Cancer. The American Surgeon 75:10, pages 970-975.
Crossref
Crossref
Gary J. Whitman & Eric A. Strom. (2009) Workup and Staging of Locally Advanced Breast Cancer. Seminars in Radiation Oncology 19:4, pages 211-221.
Crossref
Crossref